This episode explores the health benefits of high-dose caffeine consumption, challenging the standard 400mg daily limit, suggesting that higher intakes (up to 600mg) may offer greater cardiometabolic and longevity benefits. The discussion highlights that caffeinated coffee, unlike decaf, significantly reduces risks for Parkinson’s and Alzheimer’s by blocking adenosine receptors and enhancing dopamine activity. It also notes coffee’s role in reducing DNA damage and arrhythmia risk, while cautioning that excessive consumption (e.g., eight cups) may increase Alzheimer’s risk.